BiOptic Inc. (TPEX:6850)
26.20
-0.80 (-2.96%)
Nov 20, 2026, 11:53 AM CST
BiOptic Market Cap
BiOptic has a market cap or net worth of 866.92 million as of November 20, 2026. It is the 34,337th most valuable company in the world and the 2,040th biggest in Taiwan. Its market cap has decreased by 39.91% in one year.
Market Cap
866.92M
Enterprise Value
n/a
Revenue
n/a
Global Rank
Country Rank
#2,040 Taiwan
PE Ratio
n/a
ChartMarket Cap Chart
Since November 10, 2021, BiOptic's market cap has decreased from 1.23B to 866.92M, a decrease of -29.63%. That is a compound annual growth rate of -6.75%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 860.31M | -34.67% |
| Dec 31, 2025 | 1.32B | 1.58% |
| Dec 31, 2024 | 1.30B | -2.59% |
| Dec 29, 2023 | 1.33B | 17.65% |
| Dec 30, 2022 | 1.13B | 7.14% |
| Dec 30, 2021 | 1.06B | -14.29% |
| Nov 10, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Abnova (Taiwan) | 1.06B |
| Sunny Pharmtech | 1.03B |
| LabTurbo Biotech | 988.28M |
| Enimmune | 981.02M |
| Bio Preventive Medicine | 959.30M |
| Level Biotechnology | 921.66M |
| TCI GENE | 859.92M |
| Lukas Biomedical | 789.33M |